Trial Profile
An Open-label, single arm Phase II Trial of Photodynamic Therapy using Foscan for non-curatively-resectable bile duct carcinoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Aug 2015
Price :
$35
*
At a glance
- Drugs Temoporfin (Primary)
- Indications Biliary cancer
- Focus Therapeutic Use
- 31 May 2011 New trial record